NCT04964492

Assessment of the Hemodynamic Effect of Hydroxocabalamin in Refractory Vasodilatory Shock

CompletedOBSERVATIONAL

Trial Details

Start: 2020-01-15Est. Completion: 2021-01-08

Enrollment target: 18 participants

Locations

VasoplegiaEndothelial Dysfunction

Cardiac surgery patients have many risk factors for endothelial dysfunction (hypertension, atherosclerosis, dyslipidemia…

Caen, FranceCompleted Sep 2018

Hemodynamic InstabilityVasoplegic Syndrome

This single-institution randomized controlled trial prospective will enrolled 48 patients scheduled for an aortic valve …

Pessac, FranceCompleted Jul 18, 2017

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.